Bruntwood SciTech advances £60m Manchester Science Park overhaul 

The developer has applied to demolish the existing Greenheys Building “as soon as possible” so that it can secure the anchor tenant for the proposed 131,000 sq ft new-build block. 

Earlier this year, Bruntwood SciTech unveiled plans for a six-storey facility at Manchester Science Park. The £60m complex is the subject of a separate application. 

Designed by BDP, around half of this building is to be occupied by UK Biobank, Place North West understands. 

The medical research and development company is currently based in Stockport and announced last year that it intended to move to Manchester. 

Bruntwood SciTech, the joint venture between Bruntwood and Legal & General has applied to knock down the site’s existing building, a move that it is hoped will help secure the UK Biobank deal and pave the way for construction of the facility to begin in the third quarter of this year. 

The demolition of the Greenheys Building “will allow works to progress in line with programme deadlines required to secure the unique opportunity presented by the anchor tenant occupying this space within MSP”, according to documents submitted by planning consultant Deloitte. 

Demolition is proposed to commence this summer and the facility could complete by Q2 2026.

The replacement Greenheys Building would feature a range of labs with supporting office space from 2,500 sq ft to 22,000 sq ft.

The redevelopment of Greenheys will expand the existing life science cluster at Manchester Science Park, which is home to companies including international molecular diagnostics group Yourgene Health, Zilico, which is developing the next generation of diagnostic devices for cervical cancer, and enzyme engineering company Imperagen. 

Plans for the next phase of MSP closely follows completion of Base Building, a 120,000 sq ft building designed by Bridge Architects, last year.